In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor?

EMPEROR-Reduced trial weighs in

Related Keywords

Boston ,Massachusetts ,United States ,Portugal ,Tufts Medical Center ,Pedro Ferreira ,Coll Cardiol ,Marvina Konstam ,Empagliflozin Jardiance ,Journal Of The American College Cardiology ,American College ,